Trials / Completed
CompletedNCT03529201
QLB After Nephrectomy
Effectiveness of Quadratus Lumborum Block After Nephrectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Medical University of Lublin · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Oxycodone consumption and postoperative pain intensity in patients undergoing nephrectomy procedures. Of all study participants, 50% will obtain quadratus lumborum block (QLB).
Detailed description
Patients undergoing nephrectomy procedures will be allocated to one of the study arms. At the end of an operation, still under general anesthesia, 50% patients will obtain QLB with ropivacaine. Ultrasound-guided QLB will be performed on the side of surgery with 0.375% ropivacaine solution (0.2 mL per kg). Every patient will get patient-controlled analgesia pump with oxycodone in the postoperative period. Postoperative pain will be measured with VAS (visual-analogue scale) 2, 4, 8, 12 and 24 hours after the end of the operation. 24 -hours period. At the 1, 3, 6 months patients will be interviewed by phone to assess neuropathic pain. Neuropathic Pain Symptom Inventory (NPSI) will be used.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | QLB | On the side of the surgery, QLB with 0.375% ropivacaine (0.2 mL/kg) |
| DEVICE | PCA | Patient-controlled analgesia |
| PROCEDURE | GA | General anesthesia |
| DRUG | Oxycodone | administered by PCA |
| DRUG | Sevoflurane | Inhalational anesthetic during GA |
| DRUG | Fentanyl | painkiller during GA |
| DRUG | Rocuronium | muscle relaxant during GA |
Timeline
- Start date
- 2018-05-07
- Primary completion
- 2019-02-28
- Completion
- 2019-08-25
- First posted
- 2018-05-18
- Last updated
- 2023-11-24
Locations
2 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT03529201. Inclusion in this directory is not an endorsement.